FDA-Approved Drug Shows Promise for Reversing Osteoarthritis Damage
2 Articles
2 Articles
FDA-Approved Drug Shows Promise for Reversing Osteoarthritis Damage
Researchers at Yale have identified lacosamide, an FDA-approved medication, as a promising new treatment for osteoarthritis that may both relieve pain and repair damaged cartilage. For millions of people with osteoarthritis, everyday activities are often limited by persistent pain and joint stiffness. Treatments such as over-the-counter pain relievers and steroid injections can ease discomfort for [...]
Researchers at Yale University have identified lacosamide, an FDA-approved drug, as a promising new option for treating osteoarthritis. The study, published in the journal Bioactive Materials, reveals that lacosamide not only relieves joint pain but can also reverse cartilage damage. The study reveals the effectiveness of lacosamide in cartilage repair. The results indicate that lacosamide demonstrated significant efficacy in reducing joint pain…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
